Brazil's pharmaceutical market — the largest in Latin America and among the world's top ten pharmaceutical markets — is driven by universal healthcare coverage through SUS (Sistema Único de Saúde), an aging population, expanding middle class, and significant generic drug industry, with the Brazil Pharmaceutical Industry Market reflecting Brazil's strategic...
A "Historic Shift" in Brazilian pharmaceutical policy has occurred in 2026, as the country officially opens its doors to "Domestic Cannabis Cultivation" for medical and research purposes. We are seeing the Brazil Pharmaceutical Industry Market expanded by a series of "ANVISA Resolutions" (Nos. 1,011 to 1,015) published in February 2026. This year, authorized companies can finally plant, grow,...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
คลิกดาวน์โหลด
thai 
English
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china